Name | Cevimeline |
Synonyms | Evoxac AF-102B SNI-2011 Cevimeline CevimelineHClSalt 2-methyspiro(1,3-oxathiolane-5,3)quinuclidine Spiro[1-azabicyclo[2.2.2]octane-3,5'-[1,3]oxathiolane], 2'-methyl-, cis- Spiro[1-azabicyclo[2.2.2]octane-3,5'-[1,3]oxathiolane], 2'-methyl-, (2'R,3R)-rel- |
CAS | 107233-08-9 |
Molecular Formula | C10H17NOS |
Molar Mass | 199.31 |
Density | 1.19 |
Melting Point | 195-197°C |
Boling Point | 308.5±42.0 °C(Predicted) |
pKa | 9.51±0.40(Predicted) |
Storage Condition | Sealed in dry,Store in freezer, under -20°C |
In vitro study | In digested parotid cells, Cevimeline (0.1-100 μM) increases the intracellular Ca 2+ concentration. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 5.017 ml | 25.085 ml | 50.171 ml |
5 mM | 1.003 ml | 5.017 ml | 10.034 ml |
10 mM | 0.502 ml | 2.509 ml | 5.017 ml |
5 mM | 0.1 ml | 0.502 ml | 1.003 ml |